Adriblastina RD

Adriblastina RD Indications/Uses





Full Prescribing Info
Doxorubicin is indicated in the treatment of the following cancers: acute lymphoblastic leukemia; acute myelogenous leukemia; chronic leukemias; Hodgkin's & non-Hodgkin's lymphoma; multiple myeloma; osteosarcoma; Ewing's sarcoma; soft tissue sarcoma; neuroblastoma; rhabdomyosarcoma; Wilms' tumor; breast cancer, including as a component of adjuvant therapy in women with evidence of axillary lymph node involvement following resection of primary breast cancer; endometrial cancer; ovarian cancer; non-seminomatous testicular cancer; prostate cancer; transitional cell bladder cancer; lung cancer; stomach (gastric) cancer; primary hepatocellular cancer; head and neck cancer; thyroid cancer.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in